^
+ Follow OTSUKA PHILIPPINES Tag
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 908491
                    [Title] => Tolvaptan effective for hyponatremia for patients with heart failure — trials
                    [Summary] => 

Tolvaptan, a new vasopressin V2-receptor antagonist and the first and only oral drug in its class, has been shown in clinical trials to be an effective treatment for hypervolemic and euvolemic hyponatremia, especially for patients with heart failure, cirrhosis, and Syndrome of Inappropriate Antidiuretic Hormone (SIADH).

[DatePublished] => 2013-02-14 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 887879 [Title] => Otsuka Philippines celebrates 15th year [Summary] =>

Otsuka Philippines, one of the leading Japanese pharmaceutical companies in the Philippines, celebrated its 15th anniversary celebration last Dec. 4 at the Marriott Hotel.

[DatePublished] => 2012-12-20 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => http://imageshack.us/a/img338/6591/scitec4newthumb.jpg ) [2] => Array ( [ArticleID] => 404112 [Title] => Effort on to promote liver wellness [Summary] => In response to the alarming situation of chronic liver disease in the country, Otsuka (Philippines) Pharmaceutical Inc. ... [DatePublished] => 2008-10-02 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
OTSUKA PHILIPPINES
Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 908491
                    [Title] => Tolvaptan effective for hyponatremia for patients with heart failure — trials
                    [Summary] => 

Tolvaptan, a new vasopressin V2-receptor antagonist and the first and only oral drug in its class, has been shown in clinical trials to be an effective treatment for hypervolemic and euvolemic hyponatremia, especially for patients with heart failure, cirrhosis, and Syndrome of Inappropriate Antidiuretic Hormone (SIADH).

[DatePublished] => 2013-02-14 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) [1] => Array ( [ArticleID] => 887879 [Title] => Otsuka Philippines celebrates 15th year [Summary] =>

Otsuka Philippines, one of the leading Japanese pharmaceutical companies in the Philippines, celebrated its 15th anniversary celebration last Dec. 4 at the Marriott Hotel.

[DatePublished] => 2012-12-20 00:00:00 [ColumnID] => 0 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => http://imageshack.us/a/img338/6591/scitec4newthumb.jpg ) [2] => Array ( [ArticleID] => 404112 [Title] => Effort on to promote liver wellness [Summary] => In response to the alarming situation of chronic liver disease in the country, Otsuka (Philippines) Pharmaceutical Inc. ... [DatePublished] => 2008-10-02 00:00:00 [ColumnID] => 133272 [Focus] => 0 [AuthorID] => [AuthorName] => [SectionName] => Science and Environment [SectionUrl] => science-and-environment [URL] => ) ) )
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with